Schroder UK Public Private Trust, the rebranded fund previously led by Neil Woodford, has sold its shareholding in Carrick Therapeutics at a discount.

University of British Columbia spinout Paragon Testing Enterprises has agreed to an acquisition by Prometric Canada Testing Services.

Oxford spinout Vaccitech, which developed the technology underlying the university’s covid vaccine, has filed for an offering on the Nasdaq Global Market.

AST SpaceMobile, which exploits research conducted at University of Maryland, has gone public through a reverse merger with New Providence Acquisition Corp.

UC Davis spinout Dysonics was acquired by Google last year, it has emerged.

The online learning platform developer spun out of Stanford University priced its shares at the top of their range.

CWRU and UTMC-linked Rodeo Therapeutics is set to be acquired by Amgen for $55m in upfront and up to $666m in milestone payments.

Achilles Therapeutics has raised more than $175m in its initial public offering on the Nasdaq Global Select Market.

The vertical take-off and landing jet developer, an Unternehmertum spinout, is joining forces with the Nasdaq-listed Qell Acquisition Corp.

Lava Therapeutics, which is developing cancer treatments based on research at Amsterdam University Medical Centers, floated in a $101m offering.